Australian Parkinson's Genetics Study (APGS): pilot (n=1532).

Area of Science:

• Neuroscience
• Genetics
• Epidemiology

Background:

• Parkinson's disease (PD) is a progressive neurodegenerative disorder with unknown etiology.
• Genetic and environmental factors significantly influence PD risk and progression.
• Understanding these factors is crucial for developing effective interventions.

Purpose of the Study:

• To investigate the sociodemographic, genetic, and environmental basis of PD susceptibility, symptoms, and progression.
• To analyze patient-reported data from a large Australian cohort.
• To identify potential risk factors and understand disease heterogeneity.

Main Methods:

• Pilot phase recruited 1819 participants via Pharmaceutical Benefits Scheme records.
• Collected sociodemographic and patient-reported data via online/paper questionnaires.
• 1532 participants met inclusion criteria; 1499 provided DNA samples.

Main Results:

• The cohort was 65% male and 92% of European descent.
• Traumatic brain injury (TBI) was reported by 16% and associated with earlier symptom onset.
• Common comorbidities included constipation (36%), depression (34%), and anxiety (17%).

Conclusions:

• The study provides initial insights into the characteristics of the Australian PD cohort.
• Future research will explore genetic and environmental influences on PD.
• The findings will contribute to a broader understanding of PD etiology and progression.